Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q1)Mar 31, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 92.80%-3.07M | -504K | -1.68M | -114.23%-392K | 95.37%-498K | -42.6M | -289.64%-41.88M | -423.32%-7.09M | 110.58%2.76M | -138.97%-10.75M |
| Net profit before non-cash adjustment | 87.79%-6.35M | ---1.23M | ---656K | -113.33%-2.35M | 90.07%-2.12M | ---52.04M | 27.94%-15.35M | -274.18%-8.23M | 617.72%17.62M | -18,304.27%-21.3M |
| Total adjustment of non-cash items | -98.33%532K | --98K | --103K | 103.19%276K | -99.37%55K | --31.92M | -54.62%3.98M | 22,000.00%5.75M | -4,732.09%-8.66M | 31,257.14%8.78M |
| -Depreciation and amortization | -40.09%167K | --65K | --26K | 140.74%33K | -78.17%43K | --278.74K | -137.56%-74K | 57.14%44K | -132.53%-81K | 328.26%197K |
| -Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | ---- | --13.48M | --0 | ---- | ---- | --3.27M |
| -Disposal profit | ---- | ---- | ---- | ---- | ---- | --12.13M | --0 | ---- | ---- | --4.96M |
| -Net exchange gains and losses | ---- | ---- | ---- | ---- | ---- | ---1.47M | --0 | ---- | ---- | ---1.49M |
| -Remuneration paid in stock | -96.83%232K | --0 | --0 | ---- | ---- | --7.32M | 93.34%3.98M | ---- | ---- | --2.06M |
| -Other non-cash items | -28.34%133K | --33K | --77K | -94.76%11K | 105.77%12K | --185.6K | 138.94%81K | -850.00%-19K | 438.71%210K | -1,055.56%-208K |
| Changes in working capital | 112.24%2.75M | --629K | ---1.12M | 127.11%1.68M | -11.69%1.56M | ---22.48M | -1,824.24%-30.52M | -662.27%-4.61M | 72.83%-6.2M | -93.55%1.77M |
| -Change in receivables | -422.41%-9.77M | --4.49M | ---5.1M | 101.19%185K | -152.07%-9.34M | ---1.87M | -201.07%-18.14M | -90.70%468K | 24.74%-15.51M | -53.18%17.94M |
| -Change in inventory | 103.68%1.02M | --342K | ---1.76M | 316.04%2.54M | 97.71%-106K | ---27.67M | -42.79%-6.6M | 51.78%-2.07M | 190.95%611K | -72.96%-4.63M |
| -Change in payables | 62.90%11.5M | ---4.2M | --5.74M | -112.02%-1.05M | 195.36%11.01M | --7.06M | 49.95%-5.78M | -4,275.00%-3.01M | 459.02%8.7M | -40.57%-11.55M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 54.48%-135K | -33K | -78K | 36.84%-12K | 78.95%-12K | -296.57K | -228.07%-187K | 0 | -2,000.00%-19K | -5,600.00%-57K |
| Interest received (cash flow from operating activities) | -98.20%2K | 0 | 1K | 110.97K | -60.00%106K | 850.00%19K | -413.11%-191K | 1,294.74%265K | ||
| Tax refund paid | -217.2K | 93.15%-176K | 82.83%-62K | 575.29%2.42M | -102.60%-2.57M | |||||
| Other operating cash inflow (outflow) | 7K | 7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 92.57%-3.2M | ---530K | ---1.75M | -108.11%-403K | 96.11%-510K | ---43M | -221.43%-42.14M | -316.22%-7.13M | 118.76%4.97M | -149.79%-13.11M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 91.05%-4K | --0 | --0 | --0 | 99.91%-4K | ---44.71K | 105.44%237K | 99.90%-4K | 72,566.67%4.35M | -955.69%-4.36M |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---4.72M |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Investing cash flow | 91.05%-4K | --0 | --0 | --0 | 99.96%-4K | ---44.71K | 102.61%237K | 99.90%-4K | 151,200.00%9.07M | -2,098.06%-9.08M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 22.76%-213K | ---32K | --33K | 96.29%-131K | -102.45%-83K | ---275.78K | -111.99%-407K | -103.68%-126K | ---3.53M | --3.39M |
| Net common stock issuance | -88.42%2.95M | --493K | --1.4M | --0 | -96.08%1.06M | --25.52M | -0.32%26.89M | --0 | -380.26%-23.6M | --26.98M |
| Increase or decrease of lease financing | ---- | ---- | ---- | ---- | ---- | ---86.19K | --0 | --0 | 45.00%29K | ---29K |
| Net other fund-raising expenses | ---- | ---- | ---- | ---- | ---- | --3.61M | 2,757.63%3.14M | ---- | ---- | ---118K |
| Financing cash flow | -90.47%2.74M | --461K | --1.44M | 99.51%-131K | -96.77%975K | --28.76M | -2.00%29.62M | -103.68%-126K | -419.73%-26.98M | --30.23M |
| Net cash flow | ||||||||||
| Beginning cash position | -92.63%1.02M | --550K | --869K | -88.46%1.38M | -32.41%1.02M | --13.82M | 816.17%13.83M | -14.30%8.9M | -57.90%11.99M | -38.46%1.51M |
| Current changes in cash | 96.79%-458K | ---69K | ---316K | 95.88%-534K | -94.26%461K | ---14.29M | -252.79%-12.28M | -191.84%-7.26M | 28.29%-12.95M | -68.99%8.04M |
| Effect of exchange rate changes | -106.22%-93K | ---13K | ---3K | 100.81%20K | -103.96%-97K | --1.5M | -99.75%6K | -129.76%-25K | -4,468.52%-2.47M | 1,939.17%2.45M |
| End cash Position | -54.77%468K | --468K | --550K | -90.23%869K | -88.46%1.38M | --1.03M | -87.08%1.55M | -79.85%1.61M | -14.30%8.9M | -57.90%11.99M |
| Free cash flow | 92.57%-3.2M | ---530K | ---1.75M | -104.33%-403K | 97.06%-514K | ---43.05M | -141.21%-42.14M | -20.72%-7.14M | 135.17%9.32M | -167.41%-17.47M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.